Move over flu – RSV is the star of the 2026 winter season

29/08/2026

Respiratory syncytial virus (RSV) has quietly overtaken influenza to become the dominant respiratory infection of Australia’s 2026 flu season, new national figures show.

RSV outnumbers flu this winter

By the end of July, more than 97,000 cases of RSV had been notified to the National Notifiable Diseases Surveillance System (NNDSS), compared with just over 59,000 cases of influenza. That means RSV is accounting for a large share of the coughs, fevers and breathing problems sending Australians to GPs, emergency departments and urgent care clinics this winter.

While influenza has traditionally been the main focus of winter respiratory campaigns, these numbers highlight that RSV is now a major driver of illness in the community – and not just in babies and older people.

Who is being hit hardest?

Sentinel surveillance data from ASPREN shows RSV is being detected most frequently in:
- Children aged 1–4 years  
- Adults aged 20–49 years  

This pattern suggests young children and their parents or caregivers are bearing the brunt of this year’s RSV wave. 

New RSV protection under the National Immunisation Program

For the first time, Australia has routine RSV protection available under the National Immunisation Program (NIP), targeting those at highest risk of severe disease:

- Pregnant women: Abrysvo is recommended at 28–36 weeks’ gestation. It helps the mother produce antibodies that are passed to the baby before birth, offering protection in the early months of life when RSV can be most dangerous.  
- Older adults: Arexvy is available for people aged 75 and over, and for Aboriginal and Torres Strait Islander adults aged 60 and over, who face higher risks of complications such as pneumonia and hospitalisation.  Additionally, for adults aged 60 and over, Arexvy is available for purchase privately.

In addition to this, State and Territory health departments offer Nirsevimab, a preventative antibody, to infants and children less than 24 months of age.  For more information, go to https://immunisationcoalition.org.au/healthcare-professionals/rsv-guidance-and-state-territory-funding-information/

These vaccines do not stop every RSV infection, but they significantly reduce the risk of severe illness, hospitalisation and death in targeted high‑risk groups. Health authorities are urging eligible people to talk to their GP or immunisation provider about RSV vaccination alongside other recommended vaccines.

Who is at higher risk from RSV?

According to national guidance and Healthdirect information, RSV infection is most concerning for:
- Babies, especially under 6 months  
- Children with underlying heart or lung conditions  
- People with weakened immune systems  
- Older adults, particularly those with chronic illnesses  
- Aboriginal and Torres Strait Islander people, who may have a higher burden of respiratory disease

In these groups, RSV can lead to serious complications including pneumonia, worsening of existing heart or lung disease, and sometimes the need for intensive care.

What to watch for and when to seek help

RSV often starts like a typical cold, with symptoms such as:
- Runny nose, blocked nose and cough  
- Fever  
- Reduced appetite  
- Irritability or tiredness in young children  

Parents and carers should seek urgent medical help (call 000 or go to the nearest emergency department) if a child:

- Has trouble breathing, breathes very fast or has pauses in breathing  
- Has blue or grey lips or skin  
- Is very sleepy, difficult to wake, or not responding normally  
- Is not feeding or drinking, or has fewer wet nappies than usual  

Adults should seek prompt medical care if they experience severe shortness of breath, chest pain, confusion, or if their symptoms suddenly worsen after initially improving.

How to manage RSV at home

Most RSV infections can be managed safely at home, following Healthdirect advice:
- Rest and keep up fluids (water, breast milk or formula for babies).  
- Use paracetamol as directed to reduce fever and discomfort; seek advice before using any medicines in babies and young children.  
- Keep children home from childcare or school while they are unwell to reduce spread.  
- Avoid exposure to tobacco smoke, which makes breathing problems worse.

There is no specific antiviral medicine routinely used for RSV in otherwise healthy people, so treatment focuses on supportive care and monitoring for signs of worsening illness.

Protecting families this season

Public health experts say this RSV‑heavy winter reinforces the need to think broadly about respiratory infections, not just the flu. Key steps to protect families include:
- Staying up to date with all recommended vaccines (flu, COVID‑19 and RSV for those eligible).  
- Practising good hygiene: regular handwashing, covering coughs and sneezes, and cleaning frequently touched surfaces.  
- Keeping sick children and adults at home to reduce transmission.  
- Checking in with a GP or health service early for high‑risk family members, rather than waiting until symptoms are severe.

With RSV now overshadowing influenza in national case counts, authorities are watching how the season evolves and urging Australians to stay informed, make use of new prevention tools, and seek timely care if they or their children become unwell.